Vascular Closure Device Market to Reach US$ 963 Million by 2022


Free Press Release DB | Press Release Date : Dec 1, 2017  Download


Vascular Closure Device (VCD) Market: Adoption of Clip-based VCDs to Surge: Global Industry Analysis (2012 - 2016) & Opportunity Assessment (2017 – 2022)


Clinical use of arterial closure devices, also known as vascular closure devices, has experienced a substantial growth over the past decade. With rising incidence of cardiac disorders, new and improved cardiovascular treatments have been developed, which have further propelled the adoption of vascular closure devices (VCDs). According to a recently-published market study by Future Market Insights, the global market for vascular closure devices will expand steadily at a CAGR of 5.9%, and reach US$ 963 million over the forecast period, 2017-2022. Compared to manual compression techniques, vascular closure devices play a key role in lowering undue complications such as bleeding.

Read Report Overview @ https://www.futuremarketinsights.com/reports/vascular-closure-devices-market

However, increasing use of transradial arterial access, the continued requirement for post-procedure bed rest, significant costs, and device deployment complexities are observed as key deterrents for adoption of vascular closure devices. The use of VCDs is also anticipated to be influenced by a significant increase in the number of outpatient PCI procedures and the desire of patients to avoid arterial cut-down procedures. According to the report, hospitals will be the largest end-users of vascular closure devices in the next five years. By the end of 2022, over US$ 600 million revenues are anticipated to be procured globally from the end-use of vascular closure devices in hospitals.

A key insight from the report reveals that the demand for clip-based vascular closure devices will be relatively higher than compression devices and haemostasis pads. Despite the latter being top-selling products in the global vascular closure devices market, clip-based VCDs are expected to outpace them in terms of demand over the next five years. From medical standpoint, many surgeons prefer VCDs designed with active approximators that can physically close the arteriotomy by using nitinol clips. These metallic clips can also restrict MRI scanners from capturing the unnecessary structures which are immediately adjacent to the arteriotomy. These clip-based VCDs can boost procedural efficiency as well as post-procedural diagnostics for a wide range of cardiovascular treatments.

A regional analysis provided in the report reveals North America as the largest market for vascular closure devices. The region is anticipated to remain at the forefront of global expansion of vascular closure devices market through 2022. Robust healthcare marketplaces in the US, coupled with consumer lifestyles that have surged the incidence of cardiac disorders, will continue to boost North America’s presence in the global vascular closure devices market. The report also projects that Asia-Pacific excluding Japan (APEJ) region will register fastest growth in its vascular closure devices market, and rake over US$ 145 million by the end of 2022.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1809

Companies namely, Abbott Laboratories, Terumo Corporation, Cardinal Health, Inc., Medtronic plc, Cardiva Medical, Inc., Arstasis, Inc., Chitogen, Inc., Marine Polymer Technologies, Inc., Essential Medical, Inc., Scion Cardio-Vascular, Inc., Morris Innovative, Inc., Tricol Biomedical, Inc., Vascular Closure Systems, Inc., and TZ Medical, Inc. are profiled in the report as key players in the global vascular closure devices market. In the near future, several manufacturers of vascular closure devices will be focusing on reducing the existing drawbacks of using VCDs, which include extended hospitalisation, high morbidity risks, and the need for administering antibiotics. Some companies will also be focusing on advancing their umbrella on VCD technologies and improving the quality of life for patients being treated through vascular closure devices.

CONTACT:

Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com




Contact Person & Company

Name

:

Aman Harper

Company

:

Contact Numbers

Telephone No.

:

Fax No.

:

Handphone No.

:

Website

Website 1

:

Website 2

:

Youtube

:

PR Tags

:

Vascular Closure Device Market,

Address


Contact The Author



Contact Aman Harper






More Press Release From Author



Oral Solid Dosage Pharmaceutical Formulation Market Value to Reach US$ 926.3 Billion by 2027 End


Free Press Release DB :

Oral Solid Dosage Pharmaceutical Formulation Market: Emerging Markets of Latin America, APEJ and MEA to Collectively Hold over 45% Market Value Share: Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 – 2027 --> Read This Press Release !



By : Aman, Harper ( Dec 15, 2017 )
Category : Healthcare Press Release | Country : United States Press Release




Oral Controlled Release Drug Delivery Technology Market to Reach Nearly US$ 50,000 Million by 2027-End


Free Press Release DB :

Oral Controlled Release Drug Delivery Technology Market: Diffusion Controlled Release System Anticipated to be the Most Attractive Segment During the Forecast Period: Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 – 2027 --> Read This Press Release !



By : Aman, Harper ( Dec 15, 2017 )
Category : Healthcare Press Release | Country : United States Press Release




Diabetic Macular Edema Market: Segment Snapshot and Table of Content (2017-2027)


Free Press Release DB :

Diabetic Macular Edema Market: APEJ to Remain Third Largest Regional Market During the Forecast Period: Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 – 2027 --> Read This Press Release !



By : Aman, Harper ( Dec 15, 2017 )
Category : Healthcare Press Release | Country : United States Press Release





Read More Articles From Aman Harper



Disclaimer

The author of the press releases are solely responsible for the content of their press releases. Freepressreleasedb.com can't be held liable for the content posted by author. Please check the accuracy of the press release before using the press release. If necessary please contact the author. Thank you.




Report Abuse